-
公开(公告)号:US08586319B2
公开(公告)日:2013-11-19
申请号:US12664641
申请日:2008-06-12
申请人: Manfred Schuster , Hans Loibner , Evelyne Janzek-Hawlat , Bernhard Peball , Stefan Stranner , Bettina Wagner , Robert Weik
发明人: Manfred Schuster , Hans Loibner , Evelyne Janzek-Hawlat , Bernhard Peball , Stefan Stranner , Bettina Wagner , Robert Weik
IPC分类号: A61K38/48
CPC分类号: A61K38/4813 , A61K38/00 , C07K14/70596 , C12N9/48 , C12N9/64
摘要: The present invention relates to recombinant ACE2 polypeptide, where the ACE2 polypeptide is present as a dimer. The dimer is formed specifically from glycosylated monomers and is used for producing pharmaceutical products with an extended half-life.
摘要翻译: 本发明涉及重组ACE2多肽,其中ACE2多肽作为二聚体存在。 二聚体特异性地由糖基化单体形成,并用于生产延长半衰期的药物产品。
-
公开(公告)号:US20100310546A1
公开(公告)日:2010-12-09
申请号:US12664641
申请日:2008-06-12
申请人: Manfred Schuster , Hans Loibner , Evelyne Janzek-Hawlat , Bernhard Peball , Stefan Stranner , Bettina Wagner , Robert Weik
发明人: Manfred Schuster , Hans Loibner , Evelyne Janzek-Hawlat , Bernhard Peball , Stefan Stranner , Bettina Wagner , Robert Weik
CPC分类号: A61K38/4813 , A61K38/00 , C07K14/70596 , C12N9/48 , C12N9/64
摘要: The present invention relates to recombinant ACE2 polypeptide, where the ACE2 polypeptide is present as a dimer. The dimer is formed specifically from glycosylated monomers and is used for producing pharmaceutical products with an extended half-life.
摘要翻译: 本发明涉及重组ACE2多肽,其中ACE2多肽作为二聚体存在。 二聚体特异性地由糖基化单体形成,并用于生产延长半衰期的药物产品。
-
公开(公告)号:US20150139942A1
公开(公告)日:2015-05-21
申请号:US14409161
申请日:2012-07-31
申请人: Hans Loibner , Manfred Schuster , Evelyne Janzek-Hawlat , Susanne Wiederkum , Bernhard Peball , Stefan Stranner , Oliver Mutschlechner , Franz Groiss , Ruth Ladenstein , Holger Lode
发明人: Hans Loibner , Manfred Schuster , Evelyne Janzek-Hawlat , Susanne Wiederkum , Bernhard Peball , Stefan Stranner , Oliver Mutschlechner , Franz Groiss , Ruth Ladenstein , Holger Lode
IPC分类号: C07K16/30 , A61K31/485 , A61K39/395 , A61K45/06
CPC分类号: C07K16/3084 , A61K31/485 , A61K39/39558 , A61K45/06 , A61K2039/505 , A61K2039/54 , A61K2039/545 , C07K2317/24 , C07K2317/734 , C07K2317/76 , A61K2300/00
摘要: The present invention relates to a method for treating a GD2 positive cancer by administering a preparation comprising an anti-GD2 antibody to a patient as a continuous intravenous infusion over 24 hours per day.
摘要翻译: 本发明涉及一种治疗GD2阳性癌症的方法,其通过以每天24小时连续静脉内输注给患者施用包含抗GD2抗体的制剂。
-
公开(公告)号:US09777068B2
公开(公告)日:2017-10-03
申请号:US14409161
申请日:2012-07-31
申请人: Hans Loibner , Manfred Schuster , Evelyne Janzek-Hawlat , Susanne Wiederkum , Bernhard Peball , Stefan Stranner , Oliver Mutschlechner , Franz Groiss , Ruth Ladenstein , Holger Lode
发明人: Hans Loibner , Manfred Schuster , Evelyne Janzek-Hawlat , Susanne Wiederkum , Bernhard Peball , Stefan Stranner , Oliver Mutschlechner , Franz Groiss , Ruth Ladenstein , Holger Lode
IPC分类号: C07K16/30 , A61K39/395 , A61K31/485 , A61K45/06 , A61K39/00
CPC分类号: C07K16/3084 , A61K31/485 , A61K39/39558 , A61K45/06 , A61K2039/505 , A61K2039/54 , A61K2039/545 , C07K2317/24 , C07K2317/734 , C07K2317/76 , A61K2300/00
摘要: The present invention relates to a method for treating a GD2 positive cancer by administering a preparation comprising an anti-GD2 antibody to a patient as a continuous intravenous infusion over 24 hours per day.
-
-
-